国药集团中联药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
191
NMPA:191
Drug Approvals
Compound Dithranol Ointment
- Product Name
- 复方地蒽酚软膏
- Approval Number
- 国药准字H20093496
- Approval Date
- Feb 7, 2024
NMPA
Compound Dithranol Ointment
- Product Name
- 复方地蒽酚软膏
- Approval Number
- 国药准字H20093495
- Approval Date
- Feb 7, 2024
NMPA
Compound Salicylic Acid Liniment
- Product Name
- 复方水杨酸搽剂
- Approval Number
- 国药准字H42022854
- Approval Date
- Apr 23, 2023
NMPA
Compound Salicylic Acid Solution
- Product Name
- 复方水杨酸溶液
- Approval Number
- 国药准字H42022329
- Approval Date
- Apr 23, 2023
NMPA
Compound Fluocinonide Tincture
- Product Name
- 复方醋酸氟轻松酊
- Approval Number
- 国药准字H42022365
- Approval Date
- Apr 23, 2023
NMPA
Methylrosanilinium Chloride Solution
- Product Name
- 甲紫溶液
- Approval Number
- 国药准字H42020314
- Approval Date
- Apr 23, 2023
NMPA
Salicylic Acid and Acetic Glacial Solution
- Product Name
- 水杨酸冰醋酸溶液
- Approval Number
- 国药准字H42022750
- Approval Date
- Apr 23, 2023
NMPA
BENZALKONIUM BROMIDE SOLUTION
- Product Name
- 苯扎溴铵溶液
- Approval Number
- 国药准字H42020440
- Approval Date
- Apr 23, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
Clinical Trials
No trials found
News
No news found